Your browser doesn't support javascript.
loading
Adjuvant therapy with Huatan Sanjie Granules improves the prognosis of patients with primary liver cancer: a cohort study and the investigation of its mechanism of action based on network pharmacology.
Yuan, Juhua; Abdurahman, Abdusami; Cui, Ning; Hao, Tengteng; Zou, Jianhua; Liu, Liren; Wu, Yu.
Afiliación
  • Yuan J; Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China.
  • Abdurahman A; Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Cui N; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Hao T; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zou J; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Liu L; Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Wu Y; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Pharmacol ; 14: 1091177, 2023.
Article en En | MEDLINE | ID: mdl-37324453
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza